RxSight (RXST) Stock Statistics & Valuation Metrics

RxSight has a market cap or net worth of $190.91M. The enterprise value is $1.77M.

Market Cap

$190.91M

Enterprise Value

$1.77M

RxSight has 41,929,222 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding

41,929,222

Owned by Insiders

6.40%

Owned by Institutions

30.78%

RxSight’s return on equity (ROE) is -0.14 and return on invested capital (ROIC) is -16.81%.

Return on Equity (ROE)

-0.14

Return on Assets (ROA)

-0.12

Return on Invested Capital (ROIC)

-16.81%

Return on Capital Employed (ROCE)

-0.17

Revenue Per Employee

291.71K

Profits Per Employee

-84.48K

Employee Count

461

Asset Turnover

0.43

Inventory Turnover

1.00

The current PE Ratio of RxSight is -3.90. RxSight’s PEG ratio is 0.11.

PE Ratio

-3.90

PS Ratio

1.70

PB Ratio

0.82

Price to FCF

11.13

Price to Operating Cash Flow

8.79

PEG Ratio

0.11

In the last 12 months, RxSight had revenue of 134.48M and earned -38.94M in profits. Earnings per share was -0.95.

Revenue

134.48M

Gross Profit

103.01M

Operating Income

-48.19M

Pretax Income

-38.88M

Net Income

-38.94M

EBITDA

-35.57M

Earnings Per Share (EPS)

-0.95

In the last 12 months, operating cash flow was 23.67M and capital expenditures -5.03M, giving a free cash flow of 18.64M billion.

Operating Cash Flow

23.67M

Free Cash Flow

18.64M

Free Cash Flow per Share

0.45

RxSight pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share

―

Dividend Yield

―

Payout Ratio

N/A

Free Cash Flow Yield

9.04%

Earnings Yield

-25.79%

Beta

1.25

52-Week Price Change

-44.56%

50-Day Moving Average

5.37

200-Day Moving Average

6.28

Relative Strength Index (RSI)

38.83

Average Volume (3m)

814.04K

RxSight upcoming earnings date is Mar 03, 2027, TBA (Not Confirmed).

Last Earnings Date

Nov 03, 2026

Next Earnings Date

Mar 03, 2027

Ex-Dividend Date

―

RxSight as a current ratio of 10.95, with Debt / Equity ratio of 4.00%

Current Ratio

10.95

Quick Ratio

9.75

Debt to Market Cap

0.02

Net Debt to EBITDA

0.25

Interest Coverage Ratio

-1204.75

In the past 12 months, RxSight has paid 66.00K in taxes.

Income Tax

66.00K

Effective Tax Rate

-0.00

RxSight EV to EBITDA ratio is -2.84, with an EV/FCF ratio of 8.04.

EV to Sales

1.23

EV to EBITDA

-2.84

EV to Free Cash Flow

8.04

EV to Operating Cash Flow

6.33

RxSight has $254.68M in cash and marketable securities with $10.32M in debt, giving a net cash position of $244.36M billion.

Cash & Marketable Securities

$254.68M

Total Debt

$10.32M

Net Cash

$244.36M

Net Cash Per Share

$5.83

Tangible Book Value Per Share

$6.11

Gross margin is 76.13%, with operating margin of -50.44%, and net profit margin of -43.80%.

Gross Margin

76.13%

Operating Margin

-50.44%

Pretax Margin

-43.69%

Net Profit Margin

-43.80%

EBITDA Margin

-43.39%

EBIT Margin

-45.59%

The average price target for RxSight is $6.86, which is 11.43% higher than the current price. The consensus rating is Neutral

Price Target

$6.86

Price Target Upside

37.56% Upside

Analyst Consensus

Neutral

Analyst Count

10

Revenue Growth Forecast

-14.26%

EPS Growth Forecast

-46.60%

Smart Score

2

AI Score

53